1. Home
  2. WEAV vs SGHT Comparison

WEAV vs SGHT Comparison

Compare WEAV & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weave Communications Inc.

WEAV

Weave Communications Inc.

SELL

Current Price

$7.40

Market Cap

593.7M

Sector

Technology

ML Signal

SELL

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

SELL

Current Price

$8.30

Market Cap

489.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
WEAV
SGHT
Founded
2011
2011
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
593.7M
489.7M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
WEAV
SGHT
Price
$7.40
$8.30
Analyst Decision
Hold
Buy
Analyst Count
4
8
Target Price
$7.40
★ $10.17
AVG Volume (30 Days)
★ 1.4M
337.0K
Earning Date
10-29-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
7.50
★ 28.16
EPS
★ N/A
N/A
Revenue
★ $239,024,000.00
$77,363,000.00
Revenue This Year
$14.72
$16.75
Revenue Next Year
$13.37
$11.78
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 16.99
N/A
52 Week Low
$4.24
$3.38
52 Week High
$7.70
$9.71

Technical Indicators

Market Signals
Indicator
WEAV
SGHT
Relative Strength Index (RSI) 63.16 47.74
Support Level $7.29 $7.77
Resistance Level $7.42 $8.82
Average True Range (ATR) 0.02 0.50
MACD -0.02 -0.09
Stochastic Oscillator 63.64 27.77

Price Performance

Historical Comparison
WEAV
SGHT

About WEAV Weave Communications Inc.

Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and generates revenue mainly from subscriptions.

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

Share on Social Networks: